Jeff Kutok's Location
Cambridge, MA, US
Jeff Kutok's Work
- Chief Scientific Officer @ Ensem Therapeutics
- Chief Scientific Officer @ 4:59 NewCo, a 5AM Ventures Company
- Chief Scientific Officer @ Epizyme
- Chief Scientific Officer @ Infinity Pharmaceuticals
- Vice President, Biology and Translational Science @ Infinity Pharmaceuticals
- Senior Director, Biology and Translational Research @ Infinity Pharmaceuticals
- Senior Director, Molecular Pathology @ Infinity Pharmaceuticals
- Director, Molecular Pathology @ Infinity Pharmaceuticals
- Associate Professor of Pathology @ Brigham and Women's Hospital, Harvard Medical School
- Assistant Professor of Pathology @ Brigham and Women's Hospital, Harvard Medical School
Jeff Kutok's Education
- State University of New York at Stony Brook
Doctor of Philosophy (Ph.D.) (Molecular and Cellular Pathology)
1988 - 1995 - Stony Brook University Health Sciences Center School of Medicine
Doctor of Medicine (M.D.)
1988 - 1995
Jeff Kutok's Skills
- Laboratory
- Immunohistochemistry
- Biology
- Molecular Pathology
- Marketing
- Immunology
- Drug Discovery
- Molecular Biology
- Lifesciences
- Customer Service
Jeff Kutok's Summary
Jeff Kutok, based in Cambridge, MA, US, is currently a Chief Scientific Officer at Ensem Therapeutics, bringing experience from previous roles at 4:59 NewCo, a 5AM Ventures Company, Epizyme and Infinity Pharmaceuticals. Jeff Kutok holds a 1988 - 1995 Doctor of Philosophy (Ph.D.) in Molecular and Cellular Pathology @ State University of New York at Stony Brook. With a robust skill set that includes Laboratory, Immunohistochemistry, Biology, Molecular Pathology, Marketing and more, Jeff Kutok contributes valuable insights to the industry. Jeff Kutok has 1 email on RocketReach.
5 free lookups per month.
No credit card required.
If you need more lookups,
subscriptions start at $48 USD/month.
Not the Jeff Kutok you were looking for?
Find contact details for 700 million professionals.
People Like Jeff Kutok
-
22
-
1
-
11
-
ViewLindsey Roeker
Clinical Fellow at Memorial Sloan Kettering Cancer Center
New York, New York, United States1 -
31
-
31
-
41
-
2
-
View
Lillian Chen
Director, Global Product and Market Planning at REGENXBIO Inc.
California, United States31 -
5+5+
-
32
-
21
-
35+
Top Ensem Therapeutics Employees
-
24
-
13
-
32
-
53
-
34
-
43
-
41
-
34
-
32
-
35+
-
ViewHongbo Deng
Director of Medicinal Chemistry at Ensem Therapeutics
Cambridge, Massachusetts, United States31 -
View
Upul Bandarage
Associate Director, Medicinal Chemistry at Ensem Therapeutics
Lexington, Massachusetts, United States45+ -
51
-
11
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups / month.
Search
Search over 700
million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers
(business & personal).
G2Crowd Trusted
300K+
Plugin Users
